• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基线血清游离轻链在免疫球蛋白轻链型心脏淀粉样变性中的预后价值]

[The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].

作者信息

Wang L M, Wang T T, Tian Y, Zhao L, Yang X C, Chen W M

机构信息

Department of Geriatrics, Beijing NO.6 Hospital, Beijing 100007, China.

Department of Hematology, Beijing Chaoyang Hospital of Capital Medical University, Beijing 100020, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):47-53. doi: 10.3760/cma.j.issn.0253-2727.2020.01.009.

DOI:10.3760/cma.j.issn.0253-2727.2020.01.009
PMID:32023754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7357907/
Abstract

To analyze the prognostic value of baseline serum free light chain (sFLC) in immunoglobulin light-chain cardiac amyloidosis (AL-CA) . Thirty patients diagnosed with AL-CA from January 2012 to December 2016 at Beijing Chaoyang Hospital were included in this study to retrospectively evaluate the clinical data. The cut-off value of dFLC (involved sFLC minus uninvolved sFLC) was determined according to the receiver operator characteristic curve (ROC) and grouped, the prognoses of both groups were evaluated. The onset age of all AL-CA patients was 57 years old. It occurred more commonly in men (21 cases, 70%) and the light chains of immunoglobulin composed mainly of type λ (22 cases, 73.3%) . Renal involvements occurred in 17 cases (56.7%) . The median value of difference between involved and uninvolved serum immunoglobulin free light chain levels (dFLC) was 162.9 (57.9-401.6) mg/L. More subjects in the high dFLC group had higher BNP (=0.005) , and shorter median survival than those in the low dFLC group (15 months 47 months, <0.001) . Similar results of median survival were observed when the patients were redivided by a new cut-off value of 180 mg/L for dFLC (high dFLC group: 22 months, low dFLC group: 40 months, =0.001) , or a κ/λ ratio in which patients with κ type sFLC-ratio<3.79 and λ type sFLC-ratio≥0.06 were grouped into the low sFLC-ratio (37 months) , and the reverse the high sFLC-ratio ones (25 months, =0.021) . In multivariate analysis, dFLC and New York Heart Association (NYHA) classification of cardiac function were two risk factors associated with all-cause mortality in patients, of them the hazard ratio for higher dFLC was 12.13 (95% 2.98-49.30, <0.001) . Measurement of the sFLC level could implicate the prognosis of AL-CA.

摘要

分析基线血清游离轻链(sFLC)在免疫球蛋白轻链型心脏淀粉样变性(AL-CA)中的预后价值。本研究纳入了2012年1月至2016年12月在北京朝阳医院确诊为AL-CA的30例患者,对其临床资料进行回顾性评估。根据受试者工作特征曲线(ROC)确定dFLC(受累sFLC减去未受累sFLC)的截断值并进行分组,评估两组的预后。所有AL-CA患者的发病年龄为57岁。男性更为常见(21例,70%),免疫球蛋白轻链主要由λ型组成(22例,73.3%)。17例(56.7%)出现肾脏受累。受累与未受累血清免疫球蛋白游离轻链水平差异(dFLC)的中位数为162.9(57.9 - 401.6)mg/L。高dFLC组中更多受试者的脑钠肽(BNP)更高(P = 0.005),且中位生存期比低dFLC组短(15个月对47个月,P < 0.001)。当以dFLC新的截断值180 mg/L重新分组患者时,观察到类似的中位生存期结果(高dFLC组:22个月,低dFLC组:40个月,P = 0.001),或者以κ/λ比值分组,κ型sFLC比值<3.79且λ型sFLC比值≥0.06的患者分为低sFLC比值组(37个月),反之则为高sFLC比值组(25个月,P = 0.021)。在多因素分析中,dFLC和纽约心脏协会(NYHA)心功能分级是与患者全因死亡率相关的两个危险因素其中dFLC升高的风险比为12.13(95% 2.98 - 49.30,P < 0.001)。sFLC水平的检测可提示AL-CA的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/7357907/7ac17bd328bf/cjh-41-01-047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/7357907/c6c5b0a7f792/cjh-41-01-047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/7357907/7ac17bd328bf/cjh-41-01-047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/7357907/c6c5b0a7f792/cjh-41-01-047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/7357907/7ac17bd328bf/cjh-41-01-047-g002.jpg

相似文献

1
[The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].[基线血清游离轻链在免疫球蛋白轻链型心脏淀粉样变性中的预后价值]
Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):47-53. doi: 10.3760/cma.j.issn.0253-2727.2020.01.009.
2
[The prognostic value of baseline serum free light chain in cardiac amyloidosis].[基线血清游离轻链在心脏淀粉样变性中的预后价值]
Zhonghua Nei Ke Za Zhi. 2016 Mar;55(3):186-90. doi: 10.3760/cma.j.issn.0578-1426.2016.03.006.
3
[The diagnostic and prognostic values of serum free light chain in patients with primary light chain amyloidosis].[血清游离轻链在原发性轻链淀粉样变性患者中的诊断及预后价值]
Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):942-945. doi: 10.3760/cma.j.issn.0253-2727.2016.11.003.
4
Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis.诊断时血清游离轻链水平低的淀粉样变性患者的结局。
Amyloid. 2018 Sep;25(3):156-159. doi: 10.1080/13506129.2018.1490261. Epub 2018 Jul 21.
5
Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels.无法检测到游离轻链水平的轻链淀粉样变性患者的临床表现和预后。
Ann Hematol. 2018 Dec;97(12):2465-2470. doi: 10.1007/s00277-018-3460-0. Epub 2018 Jul 28.
6
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.初诊时游离轻链水平低的 AL 淀粉样变性患者具有极佳的预后。
Blood. 2017 Aug 3;130(5):632-642. doi: 10.1182/blood-2017-02-767475. Epub 2017 May 26.
7
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.原发性淀粉样变中单克隆免疫球蛋白游离轻链的检测:预后价值及其与临床特征的相关性。
Blood. 2010 Dec 9;116(24):5126-9. doi: 10.1182/blood-2010-06-290668. Epub 2010 Aug 26.
8
[Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].[血清游离轻链对新诊断多发性骨髓瘤患者肾功能及预后的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Dec;27(6):1862-1868. doi: 10.19746/j.cnki.issn.1009-2137.2019.06.025.
9
Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.B型利钠肽在检测免疫球蛋白淀粉样变性心脏受累中的应用
Int Heart J. 2019 Sep 27;60(5):1106-1112. doi: 10.1536/ihj.19-043. Epub 2019 Sep 4.
10
Posttreatment dFLC less than 10 mg/L predicts superior organ response and longer time to next treatment in newly diagnosed light-chain amyloidosis patients treated with bortezomib.对于新诊断的轻链淀粉样变性患者,硼替佐米治疗后游离轻链(dFLC)小于 10mg/L 预测器官反应更好,且下一次治疗的时间更长。
Leuk Lymphoma. 2021 Apr;62(4):874-882. doi: 10.1080/10428194.2020.1849675. Epub 2020 Nov 20.

引用本文的文献

1
Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis.中国免疫球蛋白轻链淀粉样变患者的预后因素:范围综述和荟萃分析。
Ann Med. 2024 Dec;56(1):2386635. doi: 10.1080/07853890.2024.2386635. Epub 2024 Aug 12.

本文引用的文献

1
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.免疫球蛋白轻链 AL 淀粉样变性患者心脏淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Mar 20;10(1):1269. doi: 10.1038/s41467-019-09133-w.
2
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis.肾脏与心脏轻链淀粉样变患者的临床特征、实验室特征和转归。
Br J Haematol. 2019 May;185(4):701-707. doi: 10.1111/bjh.15832. Epub 2019 Mar 5.
3
Outcome of Cardiac Light-Chain Amyloidosis in the Era of Novel Therapy - A Single-Center Cohort Study of 227 Patients.
新型治疗时代心脏轻链淀粉样变的转归 - 227 例患者的单中心队列研究。
Circ J. 2019 Mar 25;83(4):775-782. doi: 10.1253/circj.CJ-18-1048. Epub 2019 Feb 16.
4
Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis.近期系统性轻链淀粉样变的诊断、风险分层和治疗进展。
Acta Haematol. 2019;141(2):93-106. doi: 10.1159/000495455. Epub 2019 Jan 16.
5
Systemic immunoglobulin light chain amyloidosis.系统性免疫球蛋白轻链淀粉样变性。
Nat Rev Dis Primers. 2018 Oct 25;4(1):38. doi: 10.1038/s41572-018-0034-3.
6
Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.开发并验证了一个包含 BNP 的生存分期系统,用于轻链淀粉样变性患者。
Blood. 2019 Jan 17;133(3):215-223. doi: 10.1182/blood-2018-06-858951. Epub 2018 Oct 17.
7
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.免疫球蛋白轻链淀粉样变性:2018 年诊断、预后和治疗更新。
Am J Hematol. 2018 Sep;93(9):1169-1180. doi: 10.1002/ajh.25149.
8
Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.心肌内炎症预示着心脏 AL 淀粉样变性患者的不良预后。
Eur J Heart Fail. 2018 Apr;20(4):751-757. doi: 10.1002/ejhf.1039. Epub 2017 Oct 25.
9
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.初诊时游离轻链水平低的 AL 淀粉样变性患者具有极佳的预后。
Blood. 2017 Aug 3;130(5):632-642. doi: 10.1182/blood-2017-02-767475. Epub 2017 May 26.
10
Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?轻链淀粉样变性:轻链来自何处以及它们如何发挥致病作用?
Blood Rev. 2017 Jul;31(4):261-270. doi: 10.1016/j.blre.2017.03.002. Epub 2017 Mar 8.